Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
2.000
+0.070 (3.63%)
At close: Aug 19, 2026, 4:00 PM EDT
1.980
-0.020 (-1.00%)
After-hours: Aug 19, 2026, 6:43 PM EDT

Karyopharm Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
54.9860.5462.4852.23135.19190.46
Short-Term Investments
10.133.246.24139.21142.7838.16
Cash & Short-Term Investments
65.1163.74108.71191.44277.97228.62
Cash Growth
25.94%-41.36%-43.21%-31.13%21.59%-8.28%
Receivables
29.8726.1830.7727.9654.8923.9
Inventory
3.994.044.743.044.224.11
Prepaid Expenses
7.419.1912.2510.8112.0212.64
Restricted Cash
---0.661.066.35
Total Current Assets
106.38103.15156.46233.92350.16275.61
Property, Plant & Equipment
4.354.656.284.887.389.56
Long-Term Accounts Receivable
-----19.51
Other Long-Term Assets
0.590.621.671.640.630.64
Total Assets
111.32108.42164.42240.44358.17305.31

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7.6645.113.122.771.6
Accrued Expenses
78.864.560.6561.3958.4269.12
Short-Term Debt
--24.43---
Current Portion of Long-Term Debt
40.3121.01----
Current Portion of Leases
1.070.970.443.312.872.32
Other Current Liabilities
6.391.581.641.651.850.68
Total Current Liabilities
134.2392.0692.2669.4865.9173.72
Long-Term Debt
281.97278.22236.45303.4302.82302.29
Long-Term Leases
5.185.746.712.796.18.97
Other Long-Term Liabilities
20.125.3215.010.98--
Total Liabilities
441.49401.34350.44376.64374.83384.98

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
1,5191,4661,3781,3511,3281,099
Retained Earnings
-1,849-1,759-1,563-1,487-1,344-1,179
Comprehensive Income & Other
0.040.07-0.36-0.16-0.640.19
Shareholders' Equity
-330.17-292.93-186.02-136.21-16.66-79.67
Total Liabilities & Equity
111.32108.42164.42240.44358.17305.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
328.53305.95268.02309.5311.79313.58
Net Cash (Debt)
-263.43-242.2-159.31-118.05-33.83-84.96
Net Cash Growth
------
Net Cash Per Share
-13.57-22.15-18.84-15.50-6.20-16.94
Filing Date Shares Outstanding
22.6818.348.427.677.565.28
Total Common Shares Outstanding
22.6818.318.417.667.555.05
Working Capital
-27.8611.0964.2164.44284.25201.89
Book Value Per Share
-14.56-16.00-22.11-17.78-2.21-15.78
Tangible Book Value
-330.17-292.93-186.02-136.21-16.66-79.67
Tangible Book Value Per Share
-14.56-16.00-22.11-17.78-2.21-15.78
Machinery
-2.212.212.292.332.25
Leasehold Improvements
-3.44.884.885.455.45
SEC Filings: 10-K · 10-Q